Abstract
Chronic nephropathy is one of the oldest recognized health effects of lead; yet less is known about dose and renal effects than for any of the other major health effects of lead. Some of the reason for this is that chronic renal disease from lead exposure does not become evident until late in life and usually after many years of excessive exposure. At that time exposure information may not be available. In fact, the role of lead may not be recognized since the pathological changes in the late stages are not specific so that it is difficult to differentiate lead nephropathy from any other form of chronic renal failure. The succession of morphological and functional changes characteristic of renal effects of lead have been determined from studies of animal models and workmen exposed to lead. In this brief review a sequence of pathological changes is described comparing similarities and differences in experimental models and man. Current studies to identify biologic markers or diagnostic criteria for the early recognition of lead nephropathy are also reviewed. Finally, results of recent studies in animals will be presented that suggest that there is a threshold level of lead exposure for the onset of acute renal tubular cell effects to occur and that these observations are consistent with the few reported observations of minimal renal lead effects in humans.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
R.A. Goyer, The nephrotoxic effects of lead In: “Nephrotoxicity, Assessment and Pathogenesis”, P.H. Bach, F.W. Bonner, J.W. Bridges, and E.A. Lock, eds. John Wiley and Sons, New York (1982).
R.A. Goyer, and M.H. Wilson, Lead-induced inclusion bodies: results of EDTA treatment, Lab. Invest. 32:149 (1975).
K. Cramer, R.A. Goyer, O.R. Jagenburg, and M.H. Wilson, Renal ultra-structure, renal function and parameters of lead toxicity in workers with different lengths of lead exposure, Brit. J. Indust. Med. 31: 113 (1974).
V. Batuman, J.K. Maesala, B. Haddad, E. Tepper, E. Landry and R. Wedeen, The role of lead in gout nephropathy, N. Engl. J. Med. 304:520 (1981).
P. Mao, and J.J. Molnar, The fine structure and histochemistry of lead-induced renal tumors in rats, Am. J. Pathol. 50:571 (1967).
E.L. Baker, R.A. Goyer, B.A. Fowler, U. Khettry, O.B. Bernard, S. Adler, R. White, R. Babayan and R.G. Feldman, Occupational lead exposure, nephropathy and renal cancer, Am. J. Indust. Med. 1:139 (1980).
R. Lilis, Long-term occupational lead exposure: Chronic nephropathy and renal cancer: a case report, Am. J. Indust. Med. 2:293 (1981).
W.C. Cooper, O. Wong, L. Kheifets, Mortality among employees of lead battery plants and lead producing plants, 1947–1980, Scand. J. Work. Environ. Health. 11:331 (1985).
M. Rutter, Low level lead exposure: sources, effects and implications, In: “Lead versus Health”, (M. Rutter, and R. Russell Jones, eds. John Wiley and Sons, New York (1983).
M.R. Moore, and A. Goldberg, Health implications of the hematopoietic effects of lead. In: “Dietary and Environmental Lead: Human Health Effects”, K.R. Mahaffey, ed. Elsevier, Amsterdam (1985).
R.A. Goyer, D.L. Leonard, J.F. Moore, B. Rhyne, and M.R. Krigman, Lead dosage and the role of the intranuclear inclusion body, Arch. Environ. Health. 20:705, (1970).
G.B. Schumann, S.I. Lerner, M.A. Weiss, L. Gawronski, and G.K. Lohiya, Inclusion bearing cells in industrial workers exposed to lead, Am. J. Clin. Pathol. 74: 192 (1980).
R.G. Price, J. Halman, and C.T. Yuen, Urinary enzymes as early indicators of renal changes, In: “Occupational and Environmental Chemical Hazards”, V. Foa, E.A. Emmett, M. Maroni, and A. Colombi, eds. Ellis Horwood, Chichester (1987).
B.R. Meyer, A. Fischbein, K. Rosenman, Y. Lerman, D.E. Drayer, and M.M. Reidenberg, Increased urinary enzyme excretion in workers exposed to nephrotoxic chemicals, Am. J. Med. 76:989 (1984).
C.N. Ong, G. Endo, K.S. Chia, W.O. Phoon, H.Y. Ong, Evaluation of renal function in workers with low blood lead levels, In: “Occupational and Environmental Chemical Hazards”, V. Foa, E.A. Emmett, M. Maroni, and A. Colombi, eds. Ellis Horwood, Chichester, England (1987).
W.M. Victery, C.R. Miller and R.A. Goyer, Essential trace metal excretion from rats with lead exposure and during chelation therapy, J. Lab. Clin. Med. 107:129 (1986).
W.M. Victery, C.R. Miller, S. Zhu and R.A. Goyer, Effect of different levels and periods of lead exposure on tissue levels and excretion of lead zinc and calcium in the rat, Fund. Appl. Toxicol. 8:506 (1987).
W.M. Victery, J.M. Smith, and A.J. Wander, Renal tubular handling of zinc in the dog, Amer. J. Physiol. 241:F532–539 (1981).
V.N. Finelli, Lead, zinc, and delta-aminolevulinate, In: “Biochemical Effects of Environmental Pollutants”, S.D. Lee, ed. Ann Arbor Science, Ann Arbor (1977).
R.A. Goyer, The renal tubule in lead poisoning. I. Mitochondrial swelling and aminoaciduria, Lab. Invest. 19:71 (1968).
J.L. Farber, Membrane injury and calcium homeostasis in pathogenesis of coagulative necrosis, Lab. Invest. 47: 114 (1982).
J.G. Pounds, Effect of lead intoxication on calcium homeostasis and calcium-mediated cell function: a review, Neurotox. 5:295 (1984).
R.J. Baker, and J.A. Nelder, “The GLIM System, Release 3, Manual”, Oxford: Numerical Algorithms Group (1978).
J.P. Buchet, H. Roels, A. Bernard, and R. Lauwerys, Assessment of renal function of workers exposed to inorganic lead, cadmium or mercury vapor, J. Occup. Med. 22:741 (1980).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1989 Springer Science+Business Media New York
About this chapter
Cite this chapter
Goyer, R.A., Weinberg, C.R., Victery, W.M., Miller, C.R. (1989). Lead Induced Nephrotoxicity: Kidney Calcium as an Indicator of Tubular Injury. In: Bach, P.H., Lock, E.A. (eds) Nephrotoxicity. Springer, Boston, MA. https://doi.org/10.1007/978-1-4757-2040-2_2
Download citation
DOI: https://doi.org/10.1007/978-1-4757-2040-2_2
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4757-2042-6
Online ISBN: 978-1-4757-2040-2
eBook Packages: Springer Book Archive